In this report, we investigate a new family of cationic iridium(III) complexes featuring 2-phenylbenzimidazole cyclometallating ligand and 4,4'-dimethyl-2,2'-bipyridine ancillary ligand. Our benchmark complex IrL 1 2 (L 1 = 2-phenylbenzimidazole) displays similar emission properties than the archetypical complex 2,2'-dipyridyl-bis[2',4'-phenylpyridine]iridium(III) in deaerated CH3CN (Φ = 0.20, λem = 584 nm ; Φ = 0.14, λem = 585 nm, respectively), but exhibits a higher photoluminescence quantum yield in deaerated CH2Cl2 (Φ = 0.32, λem = 566 nm; Φ = 0.20, λem = 595 nm, respectively), and especially lower non radiative constant (knr = 6.6 x 10 5 s -1 vs knr = 1.4 x 10 6 s -1 , respectively). As primary investigation, we explored the influence of the introduction of electron donating and electron withdrawing groups on the benzimidazole moiety and the synergetic effect of the substitution of the cyclometallating phenyl moiety in para position with same substituents. The emission energy displays very good correlation with the Hammett constants of the introduced substituents as well as with ΔEredox values, which allow to ascribe the phosphorescence of these series to emanate mainly from a mixed metal/ligand to ligand charge transfer triplet excited state ( 3 M/LLCT * ). Two complexes (IrL 5 2 and IrL 8 2) display a switch of the lowest triplet excited state from 3 M/LLCT* to ligand centered ( 3 LC*), from the less polar CH2Cl2 to the more polar CH3CN. The observed results are supported by (TD)-DFT computations considering the vibrational contributions to the electronic transitions. Chromaticity diagrams based on the maximum emission wavelength of the recorded and simulated phosphorescence spectra demonstrate the strong interests of our complexes as emitting materials, together with the very good agreement between experimental and theoretical results.